Abiopharma

NICE LTD. (NICE)

Symbol	NICE
Name	NICE LTD.
Sector	TECHNOLOGY
Region	Asia
Industry	-
Address	43107 Israel 8 Hapnina Street P.O. Box 690
Telephone	972-9-7753151
Fax	03-7753379
Email	ir@nice.com
Website	http://www.nice.com
Incorporation	IL
Incorporated On	—
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC;TASE;NASDAQ
Auditor	—
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001003935
Description	Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. The company provides data analytics-based solutions through both a cloud platform and on-premises infrastructure. Within customer engagement, Nices CXOne platform delivers solutions focused on contact center software and workforce engagement management, or WEM. Contact center offerings include solutions for digital self-service, customer journey and experience optimization, and compliance. WEM products optimize call center efficiency, leveraging data and AI analytics for call volume forecasting and agent scheduling. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money laundering, and compliance solutions. Additional info from NASDAQ: Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. The company provides data analytics-based solutions through both a cloud platform and on-premises infrastructure. Within customer engagement, Nices CXOne platform delivers solutions focused on contact center software and workforce engagement management, or WEM. Contact center offerings include solutions for digital self-service, customer journey and experience optimization, and compliance. WEM products optimize call center efficiency, leveraging data and AI analytics for call volume forecasting and agent scheduling. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money laundering, and compliance solutions.

2026-08-18 12:16

Bluecrest Transforms Healthcare Experience with NiCE Copilot, Delivering 94% Call Answer Rate Improvements

2026-08-18 12:00

Bluecrest Transforms Healthcare Experience with NiCE Copilot, Delivering 94% Call Answer Rate Improvements

2026-08-14 11:28

FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Simon Zehava

2026-08-12 12:11

Currys Transforms Customer Engagement with NiCE, Driving Higher NPS and Faster Resolution

2026-08-12 12:00

Currys Transforms Customer Engagement with NiCE, Driving Higher NPS and Faster Resolution

2026-08-10 17:28

Other Report or Announcement

2026-08-10 16:59

Dayan Udi Yehuda 🟡 adjusted position in 500 shares (1 derivative) of NICE Ltd. (NICE) at $100.00 Transaction Date: Aug 07, 2026 | Filing ID: 003983

2026-08-10 12:49

NiCE Publishes 2025 Environmental, Social and Governance (ESG) Report, Demonstrating Commitment to Innovation and Sustainability

2026-08-10 12:00

NiCE Publishes 2025 Environmental, Social and Governance (ESG) Report, Demonstrating Commitment to Innovation and Sustainability

2026-08-07 20:12

📋 UDI YEHUDA DAYAN (Officer) plans to sell 500 shares of NICE LTD. (at $100.00 each, total $50K) Filed: Aug 07, 2026 | ID: 007787